Video Endoscopy Systems in North Carolina

Calla Health Foundation is a medical device company focused on improving women's access to cervical cancer prevention and screening, particularly in low-resource settings. The organization develops portable, affordable diagnostic imaging technologies and AI-driven decision support systems designed to democratize gynecological examination and cancer prevention. Their product suite includes the Pocket Colposcope (a portable, low-cost video colposcope for cervical tissue examination), the Callascope (a speculum-free cervical imaging device enabling self-screening or provider-assisted insertion), and CARE (an AI algorithm for cervical pre-cancer risk assessment). The company's innovations enable midwives and community health workers to perform point-of-care screening and "see-and-treat" management paradigms without requiring traditional hospital infrastructure or specialized physician expertise. FDA-cleared and clinically validated in multiple low- and middle-income countries.

CellSolutions LLC manufactures comprehensive liquid-based cytology platforms for clinical and research laboratories. The company specializes in sample collection, preservation, automated slide preparation, and digital image analysis solutions—primarily for gynecological and non-gynecological cytology applications. Product portfolio includes the CellSolutions 30 and F50 automated processors, the BestCyte digital imaging and screening system, the GluCyte manual preparation method, and proprietary preservative fluids. BestCyte delivers high-resolution whole-slide imaging with remote diagnostic capability, networked virtual slide storage, and AI-driven cell grouping and detection algorithms. All systems support HPV and molecular testing compatibility. The platform is designed for mid-sized labs and clinical settings requiring walk-away automation, specimen adequacy improvement, and efficient case management.

iCare is a leading ophthalmic diagnostics and screening company specializing in handheld and automated devices for detection and monitoring of glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD). The company manufactures a comprehensive product line including rebound tonometers (IOP measurement devices), confocal fundus imaging systems with TrueColor technology, automated perimetry systems with active retinal tracking, and microperimetry devices. iCare's product portfolio includes the iCare IC200 handheld tonometer (market leader in rebound tonometry with validation from over 300 clinical studies), iCare EIDON Family confocal imaging systems offering ultra-high-quality detail-rich images from posterior pole to periphery, iCare COMPASS automated perimeter combining visual field testing with retinal tracking and non-mydriatic imaging, iCare MAIA microperimetry system for mesopic confocal analysis, iCare ST500 slit lamp tonometer, and iCare ILLUME screening solution featuring AI-assisted automated imaging and processing for early detection of retinal diseases. The company also offers iCare Screening Solution, a fully automated AI-assisted system for preventive eye care. All devices are designed for ease of use with minimal training, non-mydriatic capability, and intuitive interfaces. iCare is part of the Revenio Group, which includes Icare Finland Oy, Icare USA Inc., iCare World Australia, China iCare Medical Technology, Thirona RetinaB.V., and Centervue S.P.A. The company serves ophthalmologists, optometrists, general practitioners, and diabetic clinics globally. Clinical evidence and regulatory compliance underpin all product development.